Fate Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. 

CEO
Bahram Valamehr
CEOBahram Valamehr
Employees
181
Employees181
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
181
Employees181

FATE Key Statistics

Market cap
130.11M
Market cap130.11M
Price-Earnings ratio
-0.76
Price-Earnings ratio-0.76
Dividend yield
—
Dividend yield—
Average volume
1.49M
Average volume1.49M
High today
$1.18
High today$1.18
Low today
$1.10
Low today$1.10
Open price
$1.15
Open price$1.15
Volume
940.87K
Volume940.87K
52 Week high
$5.92
52 Week high$5.92
52 Week low
$0.6611
52 Week low$0.6611

Analyst ratings

64%

of 11 ratings
Buy
36.4%
Hold
63.6%
Sell
0%

People also own

Based on the portfolios of people who own FATE. This list is generated using Robinhood data, and it’s not a recommendation.
Plug Power
NIO
CRISPR
Tilray Brands
Intellia Therapeutics
Moderna
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.